Literature DB >> 32404449

Breast Cancer Survivorship Tool: Facilitating breast cancer survivorship care for family physicians and patients.

Anna N Wilkinson1, Catherine E Boutet2.   

Abstract

OBJECTIVE: To create an evidence-based national Breast Cancer Survivorship (BCS) Tool that facilitates appropriate care of breast cancer patients by primary care providers after patients have completed adjuvant therapy. SOURCES OF INFORMATION: MEDLINE and PubMed were searched from 2002 to 2018 with the key words breast cancer, survivorship, survivorship care plan, guideline, review, meta-analysis, chemotherapy, radiotherapy, treatment complications, adverse effects, late effects, screening, health promotion, and follow up care. National or provincial cancer care organization guidelines were also reviewed. Evidence was graded as level I, II, or III. MAIN MESSAGE: The BCS Tool provides an evidence-based template to ensure seamless transitions of care from cancer centres to primary care. Four steps of survivorship care are outlined in this article: care knowledge and coordination, cancer surveillance, management of long-term side effects of treatment, and health promotion.
CONCLUSION: The BCS Tool will support primary care providers in ensuring breast cancer survivors receive high-quality, evidence-based care. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Year:  2020        PMID: 32404449      PMCID: PMC7219819     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  26 in total

1.  Endocrine therapy for breast cancer in the primary care setting.

Authors:  A Awan; K Esfahani
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

Review 2.  Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.

Authors:  Eitan Amir; Bostjan Seruga; Saroj Niraula; Lindsay Carlsson; Alberto Ocaña
Journal:  J Natl Cancer Inst       Date:  2011-07-09       Impact factor: 13.506

3.  Cancer screening practices of cancer survivors: population-based, longitudinal study.

Authors:  Eva Grunfeld; Rahim Moineddin; Nadia Gunraj; M Elisabeth Del Giudice; David C Hodgson; Janice S Kwon; Laurie Elit
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

4.  Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.

Authors:  Katherine D Crew; Heather Greenlee; Jillian Capodice; George Raptis; Lois Brafman; Deborah Fuentes; Alex Sierra; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

Review 5.  Breast cancer chemotherapy-related cognitive dysfunction.

Authors:  Tim A Ahles; Andrew J Saykin
Journal:  Clin Breast Cancer       Date:  2002-12       Impact factor: 3.225

6.  Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Authors: 
Journal:  Lancet       Date:  2015-07-23       Impact factor: 79.321

Review 7.  Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.

Authors:  James L Khatcheressian; Patricia Hurley; Elissa Bantug; Laura J Esserman; Eva Grunfeld; Francine Halberg; Alexander Hantel; N Lynn Henry; Hyman B Muss; Thomas J Smith; Victor G Vogel; Antonio C Wolff; Mark R Somerfield; Nancy E Davidson
Journal:  J Clin Oncol       Date:  2012-11-05       Impact factor: 44.544

Review 8.  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

Authors:  Carolyn D Runowicz; Corinne R Leach; N Lynn Henry; Karen S Henry; Heather T Mackey; Rebecca L Cowens-Alvarado; Rachel S Cannady; Mandi L Pratt-Chapman; Stephen B Edge; Linda A Jacobs; Arti Hurria; Lawrence B Marks; Samuel J LaMonte; Ellen Warner; Gary H Lyman; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

9.  Are primary care providers implementing evidence-based care for breast cancer survivors?

Authors:  Marian Luctkar-Flude; Alice Aiken; Mary Ann McColl; Joan Tranmer; Hugh Langley
Journal:  Can Fam Physician       Date:  2015-11       Impact factor: 3.275

10.  Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects.

Authors:  M Pistelli; A Della Mora; Z Ballatore; R Berardi
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

View more
  3 in total

Review 1.  Evolution of Oncology and Palliative Nursing in Meeting the Changing Landscape of Cancer Care.

Authors:  Kaiping Zhou; Jing Fu
Journal:  J Healthc Eng       Date:  2022-04-16       Impact factor: 3.822

2.  The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59.

Authors:  Anna N Wilkinson; Jean-Michel Billette; Larry F Ellison; Michael A Killip; Nayaar Islam; Jean M Seely
Journal:  Curr Oncol       Date:  2022-08-09       Impact factor: 3.109

3.  Perceived Causes of Cancer and Corresponding Behavioral Changes: A Qualitative Study on Breast Cancer Survivors in Taiwan.

Authors:  Jasmine Niu; Duan-Rung Chen; Chiao Lo; Shao-Yi Cheng; Chiun-Sheng Huang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.